Literature DB >> 29229733

Expression of Toll-Like Receptor 2 by Dendritic Cells Is Essential for the DnaJ-ΔA146Ply-Mediated Th1 Immune Response against Streptococcus pneumoniae.

Xiaofang Wang1, Taixian Yuan1, Jun Yuan1, Yufeng Su1, Xiaoyu Sun1, Jingwen Wu1, Hong Zhang2, Xun Min3, Xuemei Zhang1, Yibing Yin4,3.   

Abstract

The fusion protein DnaJ-ΔA146Ply could induce cross-protective immunity against pneumococcal infection via mucosal and subcutaneous immunization in mice in the absence of additional adjuvants. DnaJ and Ply are both Toll-like receptor 4 (TLR4) but not TLR2 ligands. However, we found that TLR2-/- mice immunized subcutaneously with DnaJ-ΔA146Ply showed significantly lower survival rates and higher bacterial loads in nasal washes than did wild-type (WT) mice after being challenged with pneumococcal strain D39 or 19F. The gamma interferon (IFN-γ) level in splenocytes decreased in TLR2-/- mice, indicating that Th1 immunity elicited by DnaJ-ΔA146Ply was impaired in these mice. We explored the mechanism of protective immunity conferred by DnaJ-ΔA146Ply and the role of TLR2 in this process. DnaJ-ΔA146Ply effectively promoted dendritic cell (DC) maturation via TLR4 but not the TLR2 signaling pathway. In a DnaJ-ΔA146Ply-treated DC and naive CD4+ T cell coculture system, the deficiency of TLR2 in DCs resulted in a significant decline of IFN-γ production and Th1 subset differentiation. The same effect was observed in adoptive-transfer experiments. In addition, TLR2-/- DCs showed remarkably lower levels of the Th1-polarizing cytokine IL-12p70 than did WT DCs, suggesting that TLR2 was indispensable for DnaJ-ΔA146Ply-induced IL-12 production and Th1 proliferation. Thus, our findings illustrate that dendritic cell expression of TLR2 is essential for optimal Th1 immune response against pneumococci in mice immunized subcutaneously with DnaJ-ΔA146Ply.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  DnaJ-ΔA146Ply; Th1 immunity; Toll-like receptor 2; dendritic cells; protein vaccine

Mesh:

Substances:

Year:  2018        PMID: 29229733      PMCID: PMC5820941          DOI: 10.1128/IAI.00651-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  TLR signalling and the function of dendritic cells.

Authors:  Hiroaki Hemmi; Shizuo Akira
Journal:  Chem Immunol Allergy       Date:  2005

Review 3.  Tolls for B cells.

Authors:  Simon Fillatreau; Rudolf A Manz
Journal:  Eur J Immunol       Date:  2006-04       Impact factor: 5.532

4.  Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice.

Authors:  Mohd Nadeem Khan; Anju Bansal; Dhananjay Shukla; Piyush Paliwal; S K S Sarada; Sai Ram Mustoori; Pratul Kumar Banerjee
Journal:  Vaccine       Date:  2006-06-09       Impact factor: 3.641

Review 5.  The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Authors:  Miriam Merad; Priyanka Sathe; Julie Helft; Jennifer Miller; Arthur Mortha
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

Review 6.  Toll-like receptors and B cells: functions and mechanisms.

Authors:  Claire M Buchta; Gail A Bishop
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

7.  Sirtuin 1 is a key regulator of the interleukin-12 p70/interleukin-23 balance in human dendritic cells.

Authors:  Yolanda Alvarez; Mario Rodríguez; Cristina Municio; Etzel Hugo; Sara Alonso; Nieves Ibarrola; Nieves Fernández; Mariano Sánchez Crespo
Journal:  J Biol Chem       Date:  2012-08-14       Impact factor: 5.157

8.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

Review 9.  The effects of TLR activation on T-cell development and differentiation.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Ying-Xiang Yang; Anthony E T Yeo
Journal:  Clin Dev Immunol       Date:  2012-06-07

10.  Subcutaneous Immunization with Fusion Protein DnaJ-ΔA146Ply without Additional Adjuvants Induces both Humoral and Cellular Immunity against Pneumococcal Infection Partially Depending on TLR4.

Authors:  Yufeng Su; Dagen Li; Yan Xing; Hong Wang; Jian Wang; Jun Yuan; Xiaofang Wang; Fang Cui; Yibing Yin; Xuemei Zhang
Journal:  Front Immunol       Date:  2017-06-12       Impact factor: 7.561

View more
  3 in total

Review 1.  Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.

Authors:  Sudeep Kumar; Raju Sunagar; Edmund Gosselin
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

Review 2.  Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities.

Authors:  Diego A Díaz-Dinamarca; Michelle L Salazar; Byron N Castillo; Augusto Manubens; Abel E Vasquez; Fabián Salazar; María Inés Becker
Journal:  Pharmaceutics       Date:  2022-08-11       Impact factor: 6.525

Review 3.  Toll-like Receptor 2 in Autoimmune Inflammation.

Authors:  Kathryne E Marks; Kaylin Cho; Courtney Stickling; Joseph M Reynolds
Journal:  Immune Netw       Date:  2021-06-25       Impact factor: 6.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.